Uroxatral

Side effects and indications

Whenever possible, frequency information about the side effects was extracted from the labels. Aggregated frequency information for the drug and, if available, placebo is shown. To the right, you can click on shaded boxes to be taken to mentions of the side effect on the label. (In some cases, the side effect cannot be highlighted due to conversion problems.) Information about indications was extracted from the indications and usage sections of the labels.

Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels (show all 12)
1 2 3 4 5 6 7 8 9 10
Dizziness def postmarketing, 5.71% 2.8% x x x x x x x x
Headache def 2.96% 1.77% x x x x x x x x
Infection def 2.96% 0.59% x x x x x x x x
Respiratory tract infection def 2.96% 0.59% x x x x x x x x
Upper respiratory tract infection def 2.96% 0.59% x x x x x x x x
Fatigue def 2.75% 1.77% x x x x x x x x
Hypotension def postmarketing, 0.423% x x x x x x x x x x
Orthostatic hypotension def postmarketing, 0.423% x x x x x x x x x x
Syncope def postmarketing, 0.211% x x x x x x x x
Angina pectoris def postmarketing, rare x x x x x x x x
Angioedema def postmarketing, rare x x x x x x x x
Atrial fibrillation def postmarketing x x
Chest pain def postmarketing x x x x x x x x x x
Diarrhoea def postmarketing x x x x x x x x
Oedema def postmarketing x x x x x x x x
Rash def postmarketing x x x x x x x x x x
Flushing def postmarketing x x x x x x x x
Gastrointestinal disorder def postmarketing x x x x x x
Cardiac disorder def postmarketing x x x x x x
Jaundice def postmarketing x x x x x
Miosis def postmarketing x x x x x x x x
Pain def postmarketing x x x x x x x x x x
Priapism def postmarketing x x x x x x x x x x
Pruritus def postmarketing x x x x x x x x
Respiratory disorder def postmarketing x x x x x
Rhinitis def postmarketing x x x x x x x x
Tachycardia def postmarketing x x x x x x x x x x
Urticaria def postmarketing, rare x x x x x x x x
Angiopathy def postmarketing x x x x x x
Cataract def postmarketing x x x x x x x x
Cardiac fibrillation postmarketing x x x
Hepatobiliary disease def postmarketing x x x x x
Blood pressure systolic decreased postmarketing x x x x x x x x x
Arterial disorder def postmarketing, rare x x x x x x x x
Floppy postmarketing x x x x x x x x x
Change in blood pressure postmarketing x x x x x x
Intraoperative floppy iris syndrome postmarketing x x x x x x x x x
Floppy iris syndrome postmarketing x x x x x x x x x
Coronary artery disease def postmarketing, rare x x x x x x x x
Abdominal pain def x x x x x x x x x x
Elderly def x
Arrhythmia def x
Arthralgia def x
Arthritis def x
Asthenia def x
Back pain def x
Breast disorder def x
Bronchitis def x x x x x x x x x x
Bursitis def x
Cardiovascular disorder def x
Connective tissue disorder def x
Constipation def x x x x x x x x x x
Dyspepsia def x x x x x x x x x x
Eye disorder def x
Influenza def x
Arthropathy def x
Laryngitis def x
Liver disorder def x
Mediastinal disorder def x
Nausea def x x x x x x x x x x
Nervous system disorder def x
Neuralgia def x
Pharyngitis def x x x x x x x x x x
Pregnancy def x
Sinusitis def x x x x x x x x x x
Torsade de pointes def x
Ventricular tachycardia def x
Vertigo def x
Hepatocellular injury x
Malaise def x
Teratogenicity def x
Arthritis aggravated x
Erectile dysfunction def x x x x x x x x x x
Renal impairment def x
Neuropathy def x
Ischial neuralgia x
Lumbar disc lesion x
Drug interaction def x
Dissecting aortic aneurysm, thoracic x
Infestation NOS x
Hypertensive x
Cholestatic liver disease x
Indication Labels
Acute retention of urine x
Benign prostatic hyperplasia def x x x x x x x x x
Fasting def x
Hepatic impairment x
Hyperplasia def x x x x x x x x x
Hypertension def x x x x x x x x
Prostatic hyperplasia def x x x x x x x x x
Urinary retention def x

Information

More information: STITCH, PubChem and possibly Wikipedia or Medpedia

ATC Code: G04CA01

Legend

Color scheme: standard – alternative

100%    
75%    
50%    
10%    
frequent (1% to 100%)    
infrequent (0.1% to 1%)    
rare (<0.1%)    
postmarketing    
0%    
no frequency information    
not found on label    

Labels

Labels were obtained from different sources and potentially contain different sets of side effects. If you click on the label name, a HTML version of the label will be shown with proteins, chemicals and side efffects highlighted using Reflect.

  1. ALFUZOSIN HYDROCHLORIDE / UROXATRAL : 22 side effects (Drugs@FDA)
  2. alfuzosin hydrochloride / Uroxatral : 24 side effects (FDA CDER)
  3. ALFUZOSIN HYDROCHLORIDE / UROXATRAL : 32 side effects (Drugs@FDA)
  4. ALFUZOSIN HYDROCHLORIDE / UROXATRAL : 39 side effects (Drugs@FDA)
  5. alfuzosin : 44 side effects (FDA XML label)
  6. ALFUZOSIN HYDROCHLORIDE / UROXATRAL : 45 side effects (Drugs@FDA)
  7. ALFUZOSIN : 46 side effects (FDA XML label)
  8. ALFUZOSIN : 46 side effects (FDA XML label)
  9. Alfuzosin : 50 side effects (FDA XML label)
  10. ALFUZOSIN HYDROCHLORIDE / XATRAL : 69 side effects (Health Canada)